Free Trial

Chill Brands Group (CHLL) Competitors

GBX 2.10
-0.14 (-6.25%)
(As of 05/23/2024 ET)

CHLL vs. PXS, STX, INHC, IHC, PRM, KNB, TLY, ABDX, FDBK, and CNSL

Should you be buying Chill Brands Group stock or one of its competitors? The main competitors of Chill Brands Group include Provexis (PXS), Shield Therapeutics (STX), Induction Healthcare Group (INHC), Inspiration Healthcare Group (IHC), Proteome Sciences (PRM), Kanabo Group (KNB), Totally (TLY), Abingdon Health (ABDX), Feedback (FDBK), and Cambridge Nutritional Sciences (CNSL). These companies are all part of the "medical" sector.

Chill Brands Group vs.

Chill Brands Group (LON:CHLL) and Provexis (LON:PXS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, community ranking, earnings, dividends, profitability, analyst recommendations, valuation and risk.

Provexis received 55 more outperform votes than Chill Brands Group when rated by MarketBeat users. However, 66.67% of users gave Chill Brands Group an outperform vote while only 64.21% of users gave Provexis an outperform vote.

CompanyUnderperformOutperform
Chill Brands GroupOutperform Votes
6
66.67%
Underperform Votes
3
33.33%
ProvexisOutperform Votes
61
64.21%
Underperform Votes
34
35.79%

Chill Brands Group has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500. Comparatively, Provexis has a beta of 1.18, suggesting that its stock price is 18% more volatile than the S&P 500.

Chill Brands Group has a net margin of 0.00% compared to Provexis' net margin of -83.03%. Provexis' return on equity of -75.88% beat Chill Brands Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Chill Brands GroupN/A -2,802.21% -44.64%
Provexis -83.03%-75.88%-36.73%

0.0% of Chill Brands Group shares are owned by institutional investors. Comparatively, 6.4% of Provexis shares are owned by institutional investors. 24.0% of Chill Brands Group shares are owned by company insiders. Comparatively, 21.4% of Provexis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Chill Brands Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Provexis
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

In the previous week, Provexis had 1 more articles in the media than Chill Brands Group. MarketBeat recorded 1 mentions for Provexis and 0 mentions for Chill Brands Group. Chill Brands Group's average media sentiment score of 0.58 beat Provexis' score of 0.00 indicating that Chill Brands Group is being referred to more favorably in the media.

Company Overall Sentiment
Chill Brands Group Positive
Provexis Neutral

Provexis has lower revenue, but higher earnings than Chill Brands Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chill Brands Group£624.19K17.03-£3.64M-£0.01-210.00
Provexis£426.17K33.14N/AN/AN/A

Summary

Provexis beats Chill Brands Group on 8 of the 13 factors compared between the two stocks.

Get Chill Brands Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for CHLL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CHLL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CHLL vs. The Competition

MetricChill Brands GroupDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£10.63M£1.10B£5.04B£1.48B
Dividend YieldN/A3.10%2.83%11.88%
P/E Ratio-200.00481.89159.131,756.30
Price / Sales17.039,472.192,506.71284,623.01
Price / Cash11.5011.1936.2733.83
Price / BookN/A6.565.402.61
Net Income-£3.64M£127.31M£104.85M£171.44M
7 Day Performance-14.29%-2.02%-2.14%0.45%
1 Month Performance-7.89%0.15%1.68%3.39%
1 Year Performance-81.42%23.09%3.47%10.33%

Chill Brands Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PXS
Provexis
0 of 5 stars
GBX 0.58
+0.9%
N/A-17.5%£13.00M£426,168.0043.752
STX
Shield Therapeutics
0 of 5 stars
GBX 1.93
+10.0%
N/A-70.1%£15.06M£7.40M-16.0427Gap Up
INHC
Induction Healthcare Group
0 of 5 stars
GBX 12.50
flat
N/A-44.4%£11.55M£11.82M-83.3383
IHC
Inspiration Healthcare Group
0 of 5 stars
GBX 16.25
flat
N/A-63.6%£11.09M£41.08M-1,625.00210High Trading Volume
PRM
Proteome Sciences
0 of 5 stars
GBX 3.73
+6.6%
N/A-28.7%£11.01M£5.03M-373.0029Gap Down
KNB
Kanabo Group
0 of 5 stars
GBX 1.70
flat
N/A-37.1%£10.75M£1,000.00-170.0023Gap Up
TLY
Totally
1.5047 of 5 stars
GBX 6.75
-6.9%
GBX 30
+344.4%
-68.2%£13.27M£121.20M-515.001,668News Coverage
Gap Down
ABDX
Abingdon Health
0 of 5 stars
GBX 10.75
flat
N/A+12.6%£13.62M£5.34M-1,075.0084
FDBK
Feedback
0 of 5 stars
GBX 73.50
flat
N/A-49.8%£9.80M£1.02M-282.6924News Coverage
Gap Down
CNSL
Cambridge Nutritional Sciences
0 of 5 stars
GBX 4
flat
N/AN/A£9.52M£9.05M-400.0091

Related Companies and Tools

This page (LON:CHLL) was last updated on 5/23/2024 by MarketBeat.com Staff

From Our Partners